跳至主要内容
临床试验/NCT02026869
NCT02026869Unknown早期 1 期

Impact of Vaginal Administration of Metformin in Women With PCOS.

Assiut University1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2013年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
入组人数
200
试验地点
1
主要终点
Ovulation rates

研究概览

简要总结

Polycystic ovary syndrome is a common cause of irregular periods, poor ovulation and delay in achieving pregnancy. Certain drugs may help improve ovarian activity in such women as metformin. Oral administration of metformin is accompanied by undesirable side effects. The vagina proved to be a good alternative to the oral route for other drugs. Using metformin through the vagina and avoidance of such side effects, while maintaining its effectiveness, would help women to better tolerate this drug.

详细描述

PCOS is the most common of all female endocrinopathies affecting 7-10% of women. A variety of drugs have been used to help improve follicular dynamics in PCOS patients. Metformin, an insulin sensitizer long known for its antidiabetic properties, has been used in PCOS patients. One of the major factors affecting compliance are the gastrointestinal side effects associated with oral administration of metformin. Knowing that the vagina is a good absorptive surface for many drugs, it is postulated that vaginal administration of metformin could be a good alternative to the oral route, if it proves effective. Both pharmacokinetic and clinical evidences of efficacy are traced for the vaginal route of administration.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 35 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • women with PCOS according to the Rotterdam criteria
  • age 20-35 years
  • not to have received any induction of ovulation in the preceding 3 months before enrollment

排除标准

  • contraindications to metformin
  • prior surgical management of PCOS

研究组 & 干预措施

Oral metformin

Active Comparator

Metformin 850 mg tablets taken by mouth every 12 hours for 6 months

干预措施: Metformin (Drug)

Vaginal metformin

Active Comparator

Metformin 850 mg tablets taken vaginally every 12 hours for 6 months

干预措施: Metformin (Drug)

结局指标

主要结局

Ovulation rates

时间窗: 6 months

Ovulation rates assessed by transvaginal sonography (TVS) after oral versus vaginal administration of metformin in PCOS women.

次要结局

  • Therapeutic drug level(Over 24 hours after administration.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

AHMED NASR

Professor

Assiut University

研究点 (1)

Loading locations...

相似试验